We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Penumbra Inc (PEN) USD0.001

Sell:$250.00 Buy:$250.57 Change: $9.82 (3.78%)
Market closed |  Prices as at close on 26 November 2021 | Switch to live prices |
Change: $9.82 (3.78%)
Market closed |  Prices as at close on 26 November 2021 | Switch to live prices |
Change: $9.82 (3.78%)
Market closed |  Prices as at close on 26 November 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Penumbra, Inc. is a global healthcare company. The Company is engaged in the design, development, manufacturing, and marketing of medical devices. It is focused on developing and building its portfolio of products, including its thrombectomy, embolization and access technologies. The Company's neuro products include Thrombectomy, Embolization, Neurovascular access, Neurosurgical Tools, and Virtual Reality Platform. Its Vascular products include Thrombectomy and Embolization. The principal specialist physicians and healthcare providers in its two target end markets include Neuro: Interventional neuroradiologists, neurosurgeons, interventional neurologists, occupational therapists, physical therapists, and physiatrists; Vascular: Interventional radiologists, vascular surgeons, and interventional cardiologists. The common vascular and neurovascular diseases the Company focuses on are Ischemic Stroke, Brain Aneurysm, Hemorrhagic Stroke, Venous Thromboembolism, and Acute Coronary Syndrome.

Contact details

1 Penumbra
United States
+1 (510) 9952486

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$9.71 billion
Shares in issue:
37.36 million
Health Care Equipment
New York Stock Exchange
United States
US dollar

Key personnel

  • Adam Elsesser
    Chairman of the Board, Chief Executive Officer
  • Maggie Yuen
    Chief Financial Officer
  • James Pray
    President, International
  • Johanna Roberts
    Executive Vice President, General Counsel, Secretary
  • Lynn Rothman
    Executive Vice President, Chief Business Officer
  • Lambert Shiu
    Chief Accounting Officer
  • Arani Bose
    Chief Innovator, Director

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.